Who owns PHOENIX BIOTECH ACQUISITION CLASS A?

Tip: Access positions for across all investors

Analyze quarterly positions in Phoenix Biotech Acquisition Class A with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Phoenix Biotech Acquisition Class A stock

Who bought or sold PHOENIX BIOTECH ACQUISITION CLASS A this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Arch Venture Corp 1.4M $4.4M 100% Mar 2024
 View chart
Sc China Holding 150k $203k 100% Mar 2024
 View chart
Jane Street 27k $81k 100% Mar 2024
 View chart
Geode Capital Management 11k $33k 0% Mar 2024
 View chart
FNY Investment Advisers 11k $32k 100% Mar 2024
 View chart
Kestra Private Wealth Services 10k $31k 100% Mar 2024
 View chart
Pineridge Advisors 300.00 $921.000000 100% Mar 2024
 View chart
Jpmorgan Chase & Co 2.00 $6.000000 100% Mar 2024
 View chart

Who sold out of Phoenix Biotech Acquisition Class A?

Fund or Company Name Date Sold Shares Held Valued At
Meteora Capital Sep 2023 170k $1.8M
Cantor Fitzgerald, L. P. Dec 2023 155k $0
Mint Tower Capital Management B.V. Sep 2023 141k $1.5M
Yakira Capital Management Sep 2023 108k $1.2M
Clear Street Sep 2023 73k $797k
Shaolin Capital Management Sep 2023 50k $543k
Walleye Trading Advisors Dec 2023 48k $527k
Berkley W R Dec 2023 47k $519k
Walleye Trading Dec 2023 27k $297k
PenderFund Capital Management Dec 2023 100.00 $1.5k